Andrew Friedberg, Phd Email & Phone Number

Providing insight on corporate development, R&D and product strategy for biotech, pharma, diagnostics and medical device companies across the therapeutic spectrum for 19 yearsHelping strategy teams, product teams and their leaders become better at driving decision-making within their companiesRecent clients have included Ionis Pharmaceuticals, Avistone Pharmaceuticals, Venrock, EcoRI Capital, and Osage University Partners, among others

Palo Alto, Ca

Analogous to the Product Team Lead role in other organizations. Led matrix teams responsible for strategy formulation and execution around all aspects of a given product. Responsible for two to three products or development programs at any given time, including Defitelio, JZP815 (a pan-RAF inhibitor), the CombiPlex liposomal development platform, and the Jazz/Immunogen partnership. Led the cross-functional Global Molecule Team through submission and clearance of an IND for JZP815, as well as initiation of a first-in-human study.

Palo Alto, California, United States

Conceived and led the effort to secure funding and initiate planning of a Phase III trial of Xywav for the treatment of idiopathic hypersomnia. This initiative led to an sNDA approval in August 2021, which remains the only major indication expansion of any Jazz product to dateLed multiple corporate strategy processes, most notably related to Jazz business strategy in sleep medicine and neuroscience

Palo Alto, California, United States

Involved in scientific, clinical and commercial diligence on ~15 corporate development opportunities per year

San Francisco Bay Area

One of the firm’s key rare disease and oncology subject matter experts, with a focus on translational medicine and early clinical-stage strategy for novel therapeutics Practice lead for companion diagnostics and other diagnostic technologies; managed or consulted on nearly all firm activity in these areasBusiness development support and management of teams conducting due diligence for acquisition and in-licensing candidates

Easton Associates was a boutique life sciences management consulting firm founded in 2000 by former partners of the Wilkerson group. The firm was acquired by Navigant Consulting in 2012.Selected in 2009 for a 2-year secondment as the company’s sole representative to establish the first overseas office of Easton Associates in LondonResponsible for recruitment of UK consulting staff, coordinating European research efforts and liaising with European clients

Phd, Molecular And Cell Biology

Ba, Biology